Coastar Therapeutics to Present at BIO 2022
Coastar Therapeutics to Present at BIO 2022 SAN DIEGO, Jun 1, 2022 – Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it is presenting at the BIO International Convention, June 13-16 2022. Eddie Y. Chung, CEO of Coastar Therapeutics, will be making […]
Job Opening – Scientist I Analytical Development
Job Opening Scientist I Analytical Development Coastar Therapeutics is seeking a highly-motivated scientist with assay development expertise to join the analytical development team. The successful candidate will be responsible for developing analytical methods in support of the biological membrane coated virus development. Operating in a cross-functional and dynamic environment, the individual will work closely with […]
Job Opening – Scientist I Product Development
Job Opening Scientist I Product Development Coastar Therapeutics is currently seeking a talented and highly motivated molecular biologist with strong genetic engineering background to join a multidisciplinary R&D team for developing stem cell derived off-the-shelf immunotherapies. The candidate will be responsible for the design, engineering, and optimization of multiple genetically modified cell types including induced […]
Job Opening – Research Associate
Job Opening Research Associate II Coastar Therapeutics is currently seeking a talented and highly motivated research associate with molecular biology background to join the multidisciplinary R&D team. The candidate will be responsible for designing and executing experiments in support of the biological membrane coated virus development. The candidate will also be involved in developing and […]
Job Opening – Engineer I
Job Opening Engineer I Coastar Therapeutics currently has an opening for an Engineer I. The successful candidate will be responsible for providing technical support to Operations, Automation, Facilities Engineering, Product Development, Quality, and Regulatory Affairs. This position will focus on leading projects for improving and optimizing operations through implementation of new technology, providing support in […]
Coastar Therapeutics Closes Seed Round Venture Funding
News Coastar Therapeutics Closes Seed Round Venture Funding SAN DIEGO, June 30, 2021 – Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it has successfully closed seed round funding. “This is a historical moment for Coastar, and we are truly grateful […]
Coastar Therapeutics to Attend Cancer Virotherapy Conferences
Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it is attending the 6th Oncolytic Virotherapy Summit on October 26-28 in Boston, Massachusetts and the International Oncolytic Virus Conference (IOVC) on November 5-7 in Sedona, Arizona.
Coastar Therapeutics to Present at JP Morgan Conference 2022
News Coastar Therapeutics to Present at JP Morgan Conference 2022 SAN DIEGO, Jan 3, 2022 – Coastar Therapeutics Inc., an emerging biotech company focused on biological payload delivery technology for cancer immunotherapy and gene therapy, today announced that it is presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation. Eddie Y. Chung, […]